ArticleCurrent infectious disease reports2007
Zygomycosis: an emerging fungal infection with new options for management.
Article in Current infectious disease reports, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
50 citing papers in PubMed, 138 citations in OpenAlex.
- Invasive transmural fungal infection as a rare cause of thoracic aortic occlusion.Journal of vascular surgery cases and innovative techniques · 2026Article
- A Rare Case ofInfectious disease reports · 2025Article
- Successful Management of Rhino-Orbital Mucormycosis in a Diabetic Patient: A Case Report.Cureus · 2025Article
- Rhino-orbital-cerebral mucormycosis in acute myeloid leukemia patients: a case series from Sri Lanka.BMC infectious diseases · 2024Article
- To Cut (Minimally Invasively) Is to Cure: Robotic Lobectomy for Pulmonary Mucormycosis.Annals of thoracic surgery short reports · 2024Article
- Case Reports on Black Fungus of the Gastrointestinal Tract: A New Complication in COVID-19 Patients.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023Article
- Risk Factors of Rhino Orbital Mucormycosis.Cureus · 2022Article
- Rhino-orbito-cerebral mucormycosis infection in a 4-year-old Egyptian girl.Medical mycology case reports · 2022Article
- Commentary: Pneumonectomy for resection of pulmonary mucormycosis: Enough is never too much.JTCVS techniques · 2022Article
- Image challenge: A diabetic man with facial swelling following recent Covid-19 infection.Clinical infection in practice · 2022Article
- Comparing the Characteristics of Mucormycosis Between Cases with and without COVID-19; a Cross-sectional Study.Archives of academic emergency medicine · 2022Article
- An unexpected case of disseminated mucormycosis following pacemaker placement and brief course of oral corticosteroids.IDCases · 2022Article
- Novel Pathogenic Mucorales Identified Using the Silkworm Infection Model.Journal of fungi (Basel, Switzerland) · 2021Article
- Cutaneous mucormycosis arising in the skin folds of immunocompromised patients: A case series.JAAD case reports · 2021Article
- Mucormycosis: A Case Series of Patients Admitted in Non-COVID-19 Intensive Care Unit of a Tertiary Care Center during the Second Wave.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2021Article
- Successful treatment ofMedical mycology case reports · 2021Article
- Case Report: Metagenomics Next-Generation Sequencing for Diagnosing Cerebral Infarction and Infection Caused by Hematogenous Disseminated Mucormycosis in a Patient With Acute Lymphoblastic Leukemia.Frontiers in medicine · 2021Article
- Article
- Article
- Pulmonary mucormycosis: a case of pulmonary arterial hypertension, Westermark sign, and bronchopleural fistula.The Journal of international medical research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zygomycosis occurs primarily in immunosuppressed patients and those with diabetes mellitus. Diabetes remains the most common risk factor; however, zygomycosis has increased among transplant recipients and patients with hematologic malignancy. Treatment or prophylaxis with voriconazole seems to be associated with the development of zygomycosis among severely immunosuppressed patients in these latter risk groups. Rhino-orbital-cerebral zygomycosis is the most common manifestation in patients with diabetes mellitus, but transplant recipients and patients with hematologic malignancy are more likely to develop pulmonary infection. Zygomycosis remains difficult to treat and requires a multifaceted approach involving elimination of predisposing factors, surgical debridement, and antifungal therapy. Lipid formulations of amphotericin B are the treatments of choice. The use of posaconazole has been successful in salvage trials but should not be used as first-line therapy until an effective intravenous formulation is available.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.